| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 10 |
| 1 | BEVACIZUMAB | 4 |
| 2 | CYCLOPHOSPHAMIDE | 4 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 5 | DEFIBROTIDE SODIUM | 4 |
| 6 | TACROLIMUS | 4 |
| 7 | PANTOPRAZOLE | 3 |
| 8 | SELEXIPAG | 3 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 1 | DEFIBROTIDE SODIUM | 4 | 0.0011 |
| 2 | AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE | 1 | 0.0009 |
| 3 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 4 | AMPHOTERICIN B LIPOSOME | 1 | 0.0004 |
| 5 | ETHAMBUTOL HYDROCHLORIDE | 1 | 0.0004 |
| 6 | EPIRUBICIN HYDROCHLORIDE | 2 | 0.0003 |
| 7 | LETERMOVIR | 1 | 0.0003 |
| 8 | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 1 | 0.0003 |
| 9 | ISAVUCONAZONIUM SULFATE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 10 | 0.0001 |
| 4 | Sulfone [EPC] | 1 | 0.0001 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 6 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |